Prolysis: In bacteria veritas

Last week's deal with chemistry company Evotec OAI AG will help Prolysis Ltd. leverage its bacterial high throughput screening technology to elbow its way into drug discovery. Prolysis, which was spun out of Oxford University in 1998, uses in vivo bacterial assays

Read the full 428 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE